ストックスクリーナーアプリを入手
3.34
1.18%
-0.04
プレマーケット:
3.31
-0.03
-0.90%
前日終値:
$3.38
開ける：
$3.38
24時間の取引高:
197.52K
Relative Volume:
0.37
時価総額：
$1.04B
収益：
$563.46M
当期純損益:
$27.92M
株価収益率:
34.65
EPS:
0.0964
ネットキャッシュフロー:
$-146.33M
1週間 パフォーマンス:
+0.91%
1か月 パフォーマンス:
-4.57%
6か月 パフォーマンス:
-35.02%
1年 パフォーマンス:
-66.40%
1日の値動き範囲:
$3.31
$3.44
1週間の範囲:
$3.20
$3.44
52週間の値動き範囲:
$3.03
$11.85
Alvotech Stock (ALVO) Company Profile
Compare ALVO vs TAK, HLN, TEVA, ZTS, UTHR
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
ALVO
Alvotech
|
3.34 | 1.05B | 563.46M | 27.92M | -146.33M | 0.0964 |
TAK
Takeda Pharmaceutical Co Adr
|
16.25 | 52.07B | 29.91B | 1.30B | 3.49B | 0.4056 |
HLN
Haleon Plc Adr
|
9.29 | 41.28B | 14.54B | 2.22B | 2.58B | 0.4871 |
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
34.07 | 39.78B | 17.53B | 1.58B | 444.18M | 1.3457 |
ZTS
Zoetis Inc
|
81.32 | 33.57B | 9.51B | 2.64B | 2.14B | 6.0361 |
UTHR
United Therapeutics Corp
|
568.43 | 24.02B | 3.17B | 1.29B | 1.01B | 27.09 |
Alvotech Stock (ALVO) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-12-09 | 開始されました | Barclays | Underweight |
| 2025-11-04 | ダウングレード | Deutsche Bank | Buy → Hold |
| 2025-10-14 | アップグレード | Morgan Stanley | Equal-Weight → Overweight |
| 2025-09-23 | アップグレード | Deutsche Bank | Hold → Buy |
| 2025-02-14 | 開始されました | UBS | Buy |
| 2024-01-29 | アップグレード | Barclays | Equal Weight → Overweight |
| 2023-10-20 | アップグレード | Citigroup | Sell → Neutral |
| 2023-09-21 | 開始されました | Barclays | Equal Weight |
| 2022-09-07 | 開始されました | Morgan Stanley | Equal-Weight |
| 2022-09-06 | ダウングレード | Citigroup | Buy → Sell |
| 2022-07-26 | 開始されました | Citigroup | Buy |
すべてを表示
Alvotech (ALVO) 最新ニュース
Alvotech founder Robert Wessman threatens to quit Britain over ‘anti-wealth’ tax regime - Business Matters
Alvotech plans June FDA resubmissions, sees biosimilar approvals by year-end - MSN
Does Alvotech’s (ALVO) FDA Inspection Outcome Reframe Confidence in Its Biosimilar Strategy for 2026? - simplywall.st
Alvotech stock (LU2557688560): 2026 outlook reaffirmed after earnings call - AD HOC NEWS
Alvotech Earnings Call Balances Setbacks and Momentum - TipRanks
Earnings Preview: Alvotech to Report Financial Results on May 06 - 富途牛牛
Quant snapshot: Micron, Babcock & Wilcox lead strong buys as Fold Holdings, Alvotech lag - MSN
Alvotech stock (LU2557688560): latest FDA approval progress and biosimilar pipeline in focus - AD HOC NEWS
Alvotech shares rise as FDA completes Reykjavik facility inspection - MSN
Alvotech faces FDA setback for its Simponi biosimilar AVT05 - MSN
Alvotech (NasdaqGM:ALVO) Valuation Check After FDA Form 483 And Reaffirmed Approval Timelines - simplywall.st
Nordic Stocks Decrease; Alvotech Takes Biggest Hit - 富途牛牛
EBITDA of Alvotech Swedish Depository Receipt Repr 1 Sh – TURQUOISE:ALVOS - TradingView
Alvotech Plans June FDA Resubmissions, Sees Biosimilar Approvals by Year-End - MarketBeat
Transcript : Alvotech Presents at Bank of America Global Healthcare Conference 2026, May-13-2026 03 - marketscreener.com
Alvotech stock (LU2557688560): Partner Fuji Pharma reports valuation drop - AD HOC NEWS
Alvotech (ALVO) Q1 2026 Earnings Transcript - AOL.com
Alvotech (ALVO) Is Down 7.4% After FDA Form 483 on Key Site Inspection Has The Bull Case Changed? - Sahm
ALVO Stock Price, Quote & Chart | ALVOTECH SA (NASDAQ:ALVO) - ChartMill
Alvotech’s Iceland Manufacturing Facility Passes FDA Surveillance Inspection - geneonline.com
Alvotech Assured After FDA Facility Feedback - Citeline News & Insights
Alvotech Receives US FDA Observations Following Iceland Plant Inspection - Moomoo
Alvotech Clears Key FDA Inspection at Reykjavik Plant, Paving Way for 2026 BLA Resubmissions - TipRanks
Alvotech (NASDAQ: ALVO) reports FDA Form 483 but maintains 2026 BLA approval outlook - Stock Titan
Alvotech advances after FDA wraps Iceland plant inspection - MSN
Alvotech announces cGMP surveillance inspection of Reykjavik facility - TipRanks
FDA completes inspection at Alvotech's Reykjavik facility; company on track for BLA resubmissions this quarter - Pluang
Alvotech announces completion of FDA surveillance inspection at Reykjavik facility - The Manila Times
Alvotech Announces Completion of FDA Surveillance Inspection at Reykjavik Facility - The Manila Times
FDA issues Form 483 at Iceland plant; Alvotech still targets 2026 drug approvals - Stock Titan
symbol__ Stock Quote Price and Forecast - CNN
Alvotech reports completion of FDA inspection in Iceland - grafa.com
Alvotech stock (LU2557688560): Q1 2026 revenue dip and EBITDA rise on mix shift - AD HOC NEWS
Dr Reddy's Share Price: Hits ₹1,303.4 On June 5 After $29.5B Keytruda Biosimilar Deal With Alvotech (x8QfRltOd3) - Fathom Journal
Alvotech Earnings Call Balances Risk and Growth - The Globe and Mail
A Look At Alvotech (NasdaqGM:ALVO) Valuation After Weak Q1 2026 Results And Biosimilar Pipeline Updates - simplywall.st
ALVOW (Alvotech) warrants remain flat as quarterly earnings data not disclosed to markets.Current Ratio - newser.com
Nordic Shares Decline; Alvotech Posts Biggest Loss - Moomoo
Alvotech Q1 2026 slides: revenue dips 20%, EBITDA rises on mix shift - Investing.com Canada
Alvotech Q1 2026 slides: revenue dips 20%, EBITDA rises on mix shift By Investing.com - Investing.com South Africa
Earnings call transcript: Alvotech misses Q1 2026 earnings, stock dips - Investing.com UK
Alvotech’s Earnings Swing And Counsel Exit Might Change The Case For Investing In ALVO - Yahoo Finance
Alvotech (NASDAQ:ALVO) Shares Gap DownTime to Sell? - MarketBeat
Alvotech Q1 2026 Financial Results - Sahm
Earnings call transcript: Alvotech misses Q1 2026 earnings, stock dips By Investing.com - Investing.com South Africa
Alvotech Q1 Earnings Call Highlights - MarketBeat
Alvotech (ALVO) 財務データ
収益
当期純利益
現金流量
EPS
1.92%
4.44%
大文字化:
|
ボリューム (24 時間):